Alder Biopharmaceuticals

Alder Biopharmaceuticals
Traded as NASDAQ: ALDR
Russell 2000 Component

Alder Biopharmaceuticals is a pharmaceutical development company based in Bothell, Washington. Alder specializes in therapeutic monoclonal antibodies. Alder went public in May 2014.[1] In early 2018, the company made a public stock offering, aiming to raise US$250 million.[2]

References

  1. ↑ "Alder BioPharmaceuticals stock flat after unexciting IPO". geekwire.com. 8 May 2014. Retrieved 24 August 2017.
  2. ↑ "Deals this week: Onconova Therapeutics, Humorigin Biotechnology, Zosano Pharma". Drug Development Technology. Kable. 2 February 2018. Retrieved 3 February 2018.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.